CD274 and gastric cancer: We retrospectively included 357 GC patients with available data on baseline blood indexes including neutrophils, monocytes and lymphocytes who received anti-PD-1/PD-L1-based treatments (1st, or 2nd, or 3rd line immunotherapy).